EarliPoint Health借助Tobii眼动追踪技术实现孤独症的早期诊断
EarliPoint Health 正以一个明确的目标革新自闭症诊断领域:尽早识别自闭症,从而改变患者的人生。
为脑损伤以及一系列神经退行性疾病和精神神经疾病提供客观的生物标志物。
我们的基于屏幕的眼动追踪技术旨在无缝集成到数字健康平台、诊断工具和认知评估产品中。该技术能够捕捉微妙的眼动模式,并将其转化为与神经和精神疾病相关的客观生物标志物,从而在研究环境之外提供临床级别的洞察。
某些眼动可以作为客观的生物标志物,指示如创伤性脑损伤、阿尔茨海默病、注意力缺陷多动障碍(ADHD)、自闭症、抑郁症和帕金森病等健康状况。通过追踪这些细微的眼动,可以实现对某些疾病的早期检测和治疗。这种方法对患者而言是非侵入性的,并有助于消除临床医生在观察过程中的偏见,从而带来更好的治疗效果。
There's a lot of software out there that's called ‘eye tracking’ that is using things like AI and machine learning projecting where the child may be looking. We can't afford that in autism. We have to have actual measurements…And that is why Tobii's our partner. Because that device has the right parallax, the right amount of measurements, and the accuracy of those measurements.
The eyes as windows into your cognitive health: We use eye tracking from Tobii for objective and accurate detection of ADHD in children and adults. Braingaze uses a scientifically proven and clinically validated biomarker captured with the Tobii 5L eye tracker for optimal performance.
I have been genuinely impressed with Tobii’s interest, support, and engagement since our partnership began. I’ve sensed strong interest and involvement from the start. My experience is that we are doing this together, and Tobii shares our goal of delivering our solutions to market.
眼见为实,试一试我们的演示项目吧!